Cleared Traditional

K202518 - Promaxo MRI System

K202518 is an FDA 510(k) clearance for Promaxo MRI System, manufactured by Promaxo, Inc.. The device is a Class 2 Radiology device with product code LNH cleared through the Traditional 510(k) pathway after a 183-day FDA review.

K202518 · Promaxo, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
183d
Days
Class 2
Risk

K202518 is an FDA 510(k) clearance for the Promaxo MRI System. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Promaxo, Inc. (Oakland, US). The FDA issued a Cleared decision on March 3, 2021 after a review of 183 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Promaxo, Inc. devices

FDA 510(k) Submission Details - K202518

510(k) Number K202518 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 01, 2020
Decision Date March 03, 2021
Days to Decision 183 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d slower than avg
Panel avg: 107d · This submission: 183d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LNH Device Classification - Class 2, Special Controls

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 840
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K202518.
MAGNETOM Vida, MAGNETOM Sola, MAGNETOM Lumina, MAGNETOM Altea
K203443 · Siemens Medical Solutions USA, Inc. · Mar 2021
Vantage Elan 1.5T, MRT-2020, V6.0
K210164 · Canon Medical Systems Corporation · Mar 2021
Vantage Galan 3T, MRT-3020, V6.0 with AiCE Reconstruction Processing Unit for MR
K203323 · Canon Medical Systems Corporation · Mar 2021
MRI PPG Patient Cable
K203653 · Ivy Biomedical Systems, Inc. · Mar 2021
Vantage Galan 3T, MRT-3020, V7.0 with AiCE Reconstruction Processing Unit for MR
K203553 · Canon Medical Systems Corporation · Feb 2021
i_Space 1.5T Superconducting Magnetic Resonance Imaging System
K192650 · Mri Division,Beijing Wandong Medical Technology Co., Ltd. · Jan 2021